Ksenija Pavletic’s interview on BFM Business France​

bg video

Ksenija Pavletic’s interview on BFM Business France​

In an insightful TV interview, Advesya’s CEO, Ksenija Pavletic, details the company’s mission to transform cancer care. The company emphasized its advances in personalized CAR T-cell therapy for the treatment of AML (Acute Myeloid Leukemia). The discussion highlighted Advesya’s significant contributions to improving patient outcomes and advancing the field of cancer treatment through innovative therapies.